TY - STD TI - World Health Organization (WHO). Global hepatitis report, 2017. Geneva, Switzerland: World Health Organization, 2017. https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ UR - https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ ID - ref1 ER - TY - BOOK PY - 2019 DA - 2019// TI - Trends and developments PB - Publications Office of the European Union CY - Luxembourg ID - ref2 ER - TY - STD TI - European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Statistical Bulletin 2020—drug-related infectious diseases. Luxembourg: Publications Office of the European Union, 2020. https://www.emcdda.europa.eu/data/stats2020/drid UR - https://www.emcdda.europa.eu/data/stats2020/drid ID - ref3 ER - TY - STD TI - European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Monitoring the elimination of viral hepatitis as a public health threat among people who inject drugs in Europe: the elimination barometer. Technical report. Luxembourg: Publications Office of the European Union, 2019. ID - ref4 ER - TY - JOUR AU - Grebely, J. AU - Larney, S. AU - Peacock, A. AU - Colledge, S. AU - Leung, J. AU - Hickman, M. PY - 2019 DA - 2019// TI - Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs JO - Addiction VL - 114 UR - https://doi.org/10.1111/add.14393 DO - 10.1111/add.14393 ID - Grebely2019 ER - TY - STD TI - European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug-related infectious diseases in Europe. Update from the EMCDDA expert network. Technical report. Luxembourg: Publications Office of the European Union, 2020. ID - ref6 ER - TY - JOUR AU - Hajarizadeh, B. AU - Grebely, J. AU - Dore, G. J. PY - 2013 DA - 2013// TI - Epidemiology and natural history of HCV infection JO - Nat Rev Gastroenterol Hepatol VL - 10 UR - https://doi.org/10.1038/nrgastro.2013.107 DO - 10.1038/nrgastro.2013.107 ID - Hajarizadeh2013 ER - TY - JOUR AU - Macías, J. AU - Morano, L. E. AU - Téllez, F. AU - Granados, R. AU - Rivero-Juárez, A. AU - Palacios, R. PY - 2019 DA - 2019// TI - Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy JO - J Hepatol VL - 71 UR - https://doi.org/10.1016/j.jhep.2019.02.018 DO - 10.1016/j.jhep.2019.02.018 ID - Macías2019 ER - TY - JOUR AU - Iversen, J. AU - Dore, G. J. AU - Catlett, B. AU - Cunningham, P. AU - Grebely, J. AU - Maher, L. PY - 2019 DA - 2019// TI - Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia JO - J Hepatol VL - 70 UR - https://doi.org/10.1016/j.jhep.2018.09.030 DO - 10.1016/j.jhep.2018.09.030 ID - Iversen2019 ER - TY - JOUR AU - Kielland, K. B. AU - Skaug, K. AU - Amundsen, E. J. AU - Dalgard, O. PY - 2013 DA - 2013// TI - All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study JO - J Hepatol VL - 58 UR - https://doi.org/10.1016/j.jhep.2012.08.024 DO - 10.1016/j.jhep.2012.08.024 ID - Kielland2013 ER - TY - STD TI - World Health Organization (WHO). Global health sector strategy on viral hepatitis 2016–2021: towards ending viral hepatitis. Geneva, Switzerland: World Health Organization, 2016. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ UR - https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ ID - ref11 ER - TY - JOUR AU - Pawlotsky, J. -. M. PY - 2018 DA - 2018// TI - Recommendations on treatment of hepatitis C 2018 JO - J Hepatol VL - 69 UR - https://doi.org/10.1016/j.jhep.2018.03.026 DO - 10.1016/j.jhep.2018.03.026 ID - Pawlotsky2018 ER - TY - JOUR AU - Larney, S. AU - Peacock, A. AU - Leung, J. AU - Colledge, S. AU - Hickman, M. AU - Vickerman, P. PY - 2017 DA - 2017// TI - Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review JO - Lancet Glob Health VL - 5 UR - https://doi.org/10.1016/S2214-109X(17)30373-X DO - 10.1016/S2214-109X(17)30373-X ID - Larney2017 ER - TY - JOUR AU - Maticic, M. AU - Lombardi, A. AU - Mondelli, U. M. AU - Colombo, M. PY - 2020 DA - 2020// TI - Elimination of hepatitis C in Europe: Can WHO targets be achieved? JO - Clin Microbiol Infect VL - 26 UR - https://doi.org/10.1016/j.cmi.2020.01.014 DO - 10.1016/j.cmi.2020.01.014 ID - Maticic2020 ER - TY - JOUR AU - Maticic, M. AU - Zorman, J. V. AU - Gregorcic, S. AU - Schatz, E. AU - Lazarus, J. V. PY - 2019 DA - 2019// TI - Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries JO - Harm Reduct J VL - 16 UR - https://doi.org/10.1186/s12954-019-0303-9 DO - 10.1186/s12954-019-0303-9 ID - Maticic2019 ER - TY - JOUR AU - Nayagam, S. AU - Thursz, M. AU - Sicuri, E. AU - Conteh, L. AU - Wiktor, S. AU - Low-Beer, D. PY - 2016 DA - 2016// TI - Requirements for global elimination of hepatitis C: a modelling study JO - Lancet Infect Dis VL - 16 UR - https://doi.org/10.1016/S1473-3099(16)30204-3 DO - 10.1016/S1473-3099(16)30204-3 ID - Nayagam2016 ER - TY - STD TI - European Centre for Disease Prevention and Control (ECDC). Monitoring the responses to hepatitis B and C epidemics in EU/EEA Member States, 2019. Stockholm: ECDC, 2020. ID - ref17 ER - TY - JOUR AU - Grebely, J. AU - Robaeys, G. AU - Bruggmann, P. AU - Aghemo, A. AU - Backmund, M. AU - Bruneau, J. PY - 2015 DA - 2015// TI - International Network for Hepatitis in Substance Users. Recommendations for the management of hepatitis C virus infection among people who inject drugs JO - Int J Drug Policy VL - 26 UR - https://doi.org/10.1016/j.drugpo.2015.07.005 DO - 10.1016/j.drugpo.2015.07.005 ID - Grebely2015 ER - TY - STD TI - Correlation-European Harm Reduction Network (C-EHRN). Homepage. Amstedam, The Netherlands: De Regenbook Groep/Correlation Network, 2020. https://www.correlation-net.org/contact-2/. UR - https://www.correlation-net.org/contact-2/ ID - ref19 ER - TY - JOUR AU - Schatz, E. AU - Schiffer, K. AU - Maher, M. AU - Harris, M. AU - Roca, X. M. AU - Maticic, M. AU - Leicht, A. PY - 2016 DA - 2016// TI - The Berlin Hepatitis C Manifesto: access to prevention, testing, treatment and care for people who use drugs JO - Hepatol Med Policy VL - 1 UR - https://doi.org/10.1186/s41124-016-0021-9 DO - 10.1186/s41124-016-0021-9 ID - Schatz2016 ER - TY - STD TI - Schatz E, Perez Gayo R, Raulet I. Good practice examples of hepatitis C prevention, testing and treatment by harm reduction services in Europe. Amsterdam, The Netherlands: Correlation-European Harm Reduction Network (C-EHRN), 2019. https://www.correlation-net.org/wp-content/uploads/2019/09/good-practice_-example_web.pdf. UR - https://www.correlation-net.org/wp-content/uploads/2019/09/good-practice_-example_web.pdf ID - ref21 ER - TY - STD TI - Schatz E, Perez Gayo R, Raulet I. Hepatitis C interventions by organisations providing harm reduction services in Europe-analysis and examples. Amsterdam, The Netherlands: Correlation-European Harm Reduction Network (C-EHRN), 2019. https://www.correlationnet.org/wpcontent/uploads/2019/07/HepInterventions_FullReport_high.pdf. UR - https://www.correlationnet.org/wpcontent/uploads/2019/07/HepInterventions_FullReport_high.pdf ID - ref22 ER - TY - STD TI - Farrell J, Schatz E. Legal Barriers for Providing HCV Community Testing in Europe. Briefing Paper. Amsterdam, The Netherlands: Correlation-European Harm Reduction Network (C-EHRN), 2019. https://www.correlation-net.org/wp-content/uploads/2019/07/HCV-Testing-Barriers-Report_FINAL.pdf. UR - https://www.correlation-net.org/wp-content/uploads/2019/07/HCV-Testing-Barriers-Report_FINAL.pdf ID - ref23 ER - TY - STD TI - Correlation-European Harm Reduction Network (C-EHRN). EU Civil Society Forum on Drugs. Amsterdam, The Netherlands: De Regenboog Groep / Correlation Network, 2018. https://www.correlation-net.org/wp-content/uploads/2018/12/Thematic-expert-group-task-description.pdf. UR - https://www.correlation-net.org/wp-content/uploads/2018/12/Thematic-expert-group-task-description.pdf ID - ref24 ER - TY - JOUR AU - Smith, J. AU - Mallouris, C. AU - Lee, K. AU - Alfven, T. PY - 2017 DA - 2017// TI - The role of civil society organizations in monitoring the Global AIDS Response JO - AIDS Behav VL - 21 UR - https://doi.org/10.1007/s10461-016-1579-3 DO - 10.1007/s10461-016-1579-3 ID - Smith2017 ER - TY - JOUR AU - Palayew, A. AU - Stumo, S. R. AU - Cooke, G. S. AU - Hutchinson, S. J. AU - Jauffret-Roustide, M. AU - Maticic, M. PY - 2020 DA - 2020// TI - The Hep-CORE policy score: a European hepatitis C national policy implementation ranking based on patient organization data JO - PLoS ONE VL - 15 UR - https://doi.org/10.1371/journal.pone.0235715 DO - 10.1371/journal.pone.0235715 ID - Palayew2020 ER - TY - JOUR AU - Zampino, R. AU - Coppola, N. AU - Sagnelli, C. AU - Caprio, G. AU - Sagnelli, E. PY - 2015 DA - 2015// TI - Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment JO - World J Hepatol VL - 7 UR - https://doi.org/10.4254/wjh.v7.i21.2323 DO - 10.4254/wjh.v7.i21.2323 ID - Zampino2015 ER - TY - JOUR AU - Scott, N. AU - Doyle, J. S. AU - Wilson, D. P. AU - Wade, A. AU - Howell, J. AU - Pedranna, A. PY - 2017 DA - 2017// TI - Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade JO - Int J Drug Policy VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.07.006 DO - 10.1016/j.drugpo.2017.07.006 ID - Scott2017 ER - TY - STD TI - World Health Organization (WHO). Viral hepatitis country profiles. Geneva, Switzerland: World Health Organization, 2019. https://www.who.int/health-topics/hepatitis#tab=tab_1. UR - https://www.who.int/health-topics/hepatitis#tab=tab_1 ID - ref29 ER - TY - JOUR AU - Robaeys, G. AU - Grebely, J. AU - Mauss, S. AU - Bruggmann, P. AU - Moussalli, J. AU - Gottardi, A. PY - 2013 DA - 2013// TI - Recommendations for the management of hepatitis C virus infection among people who inject drugs JO - Clin Infect Dis VL - 57 UR - https://doi.org/10.1093/cid/cit302 DO - 10.1093/cid/cit302 ID - Robaeys2013 ER - TY - JOUR AU - Lazarus, J. AU - Pericas, J. M. AU - Picchio, C. AU - Černoša, J. AU - Hoekstra, M. AU - Luhman, N. PY - 2019 DA - 2019// TI - We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade JO - J Intern Med VL - 286 UR - https://doi.org/10.1111/joim.12972 DO - 10.1111/joim.12972 ID - Lazarus2019 ER - TY - JOUR AU - Platt, L. AU - Reed, J. AU - Minozzi, S. AU - Hagan, H. AU - French, C. AU - Jordan, A. PY - 2017 DA - 2017// TI - Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs JO - Cochrane Database Syst Rev UR - https://doi.org/10.1002/14651858.CD012021 DO - 10.1002/14651858.CD012021 ID - Platt2017 ER - TY - STD TI - Tammi T, Rigoni R, Matičič M, Schäffer D, van der Gouwe D, Schiffer K, et al. Civil society monitoring of harm reduction in Europe, 2019. Amsterdam, The Netherlands: Correlation-European Harm Reduction Network (C-EHRN), 2019. https://www.correlation-net.org/resource-center-publications/monitoring-3/. UR - https://www.correlation-net.org/resource-center-publications/monitoring-3/ ID - ref33 ER -